Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BPH ENERGY LTD Capital/Financing Update 2010

Jul 29, 2010

64555_rns_2010-07-29_67243a66-2023-44fc-acdf-6122bba06fcc.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [171 x 81] intentionally omitted <==

30 July 2010

Companies Announcements Office Australian Securities Exchange Limited 10th Floor, 20 Bond Street SYDNEY NSW 2000

Non-renounceable Rights Issue – Letter to Security Holders

Please find attached a copy of the notice mailed to security holders of BPH today.

Yours Sincerely

==> picture [103 x 39] intentionally omitted <==

Deborah Ambrosini Company Secretary

BPH Corporate Limited ACN 95 912 002 PO Box 317, North Perth, Western Australia 6906 14 View Street, North Perth, Western Australia 6006 [email protected] www.biopharmica.com.au T: +61 8 9328 8366 F: +61 8 9328 8733

30 July 2010

==> picture [171 x 80] intentionally omitted <==

Dear Securityholder

NON-RENOUNCEABLE ENTITLEMENT ISSUE

The Company is happy to announce details of a non renounceable entitlement issue ( Issue ) of approximately 103,477,123 ordinary, fully paid shares ( Shares ) at an issue price of $0.08 per Share to raise up to approximately $8,278,170 on the basis of one (1) Share for every two (2) Shares held by Shareholders as at 7:00pm AEST on 11 August 2010.

The Issue is underwritten by Grandbridge Securities Pty Ltd.

The Prospectus relating to this Issue has been lodged with ASX and will be available on the ASX website at www.asx.com.au for inspection. Full detail of the Issue will be contained in the Prospectus, which will be mailed to all Shareholders who are registered on the Record Date. Shareholders eligible to participate should read the Prospectus carefully. The timetable and important dates of the Issue are set below:

EVENT DATE
Announcement of Issue and Appendix 3B 30 July 2010
Notice sent to Securityholders 30 July 2010
Ex Date(date from which Shares commence trading without entitlement to participate in the Issue) 5 August 2010
Record date(date for determining entitlements of eligible Shareholders to participate in the Issue) 7:00pm AEST 11 August 2010
Opening Date and dispatch of Prospectus 16 August 2010
Closing Date 7:00pm AEST 31 August 2010
Shares quoted on a deferred settlement basis 1 September 2010
Notify ASX of under subscriptions 3 September 2010
Allotment and dispatch of holding statements 6 September 2010

Optionholders will need to exercise their Options and be registered as Shareholders prior to the record date for the Issue, being 7:00pm (AEST) 11 August 2010 , in order to participate in the Issue.

The purpose of the Issue is to advance funding to the Company’s unlisted investee company Advent Energy and make further investments in the Company’s biotechnology investee entities.

Provision of additional funding to Advent Energy will allow for the drilling of Petroleum Exploration Permit 11 and further development of Advent Energy’s portfolio of petroleum exploration permits. Further investment into the Company’s biotech investee entities will assist in the development of their projects.

In calculating entitlements under the Issue, fractions will be rounded up to the nearest whole number.

The Issue is made to Shareholders with registered addresses in Australia and New Zealand. Overseas Shareholders should contact the Company Secretary, Deborah Ambrosini on +61 (0)8 9328 8366 with any queries.

Yours faithfully

Deborah Ambrosini Company Secretary

BPH Corporate Limited ACN 95 912 002 PO Box 317, North Perth, Western Australia 6906 14 View Street, North Perth, Western Australia 6006 [email protected] www.biopharmica.com.au T: +61 8 9328 8366 F: +61 8 9328 8733